Michelle Yixiao Engle, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 19
- 4 carriers
- Offices
- 2
Offices
2 locations · Indian Health Center of Santa Clara Valley · University Healthcare Alliance
Hospitals listed: Santa Clara Valley Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
19 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Engle’s office at (408) 995-5453 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
19 of 19 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A139134 · Current
Licensed to practise in California · since 2015 · expires 2027-11-30 · David Geffen School of Medicine at UCLA.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$56,862
Medicare paid this office $56,862 for 183 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 71 | $11,810 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 51 | $7,807 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $7,711 | $104 |
| Short return visit (20+ min) | 48 | $4,442 | $77 |
| Long return visit (40+ min) | 22 | $4,205 | $168 |
See all 13 services
| Return visit (30+ min) | 71 | $11,810 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 51 | $7,807 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $7,711 | $104 |
| Short return visit (20+ min) | 48 | $4,442 | $77 |
| Long return visit (40+ min) | 22 | $4,205 | $168 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $3,929 | $146 |
| Sarscov2 vac 50 mcg/0.5ml im | 17 | $2,774 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,834 | $71 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 77 | $1,780 | $13 |
| Influenza vaccine split virus, preservative free | 21 | $1,708 | $81 |
| Hospital discharge day management, 30 minutes or less | 23 | $1,618 | $70 |
| Admn sarscov2 vacc 1 dose | 18 | $990 | $52 |
| Administration of influenza virus vaccine | 22 | $841 | $38 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
183 Original Medicare patients in 2024. Average age 76 · Women 66% · Also on Medicaid 22% · Health risk score 1.42. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 68% · Diabetes 34% · Coronary heart disease 32% · Chronic kidney disease 25% · Heart failure 22% · Depression 22% · Atrial fibrillation 20% · Cancer 17% · Dementia 13% · COPD 9% · Stroke 7%.
The office billed $202,806, Medicare allowed $73,206 and paid $56,862; for 683 services of 38 kinds; $6,031 of it was for drugs given in the office and $50,831 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 183 | 683 | 76 | 1.42 | $202,806 | $56,862 |
| 2023 | 144 | 406 | 75 | 1.41 | $142,622 | $39,614 |
| 2022 | 147 | 382 | 75 | 2.13 | $141,900 | $38,780 |
| 2021 | 190 | 502 | 76 | 2.27 | $207,418 | $54,968 |
| 2020 | 99 | 249 | 75 | 2.15 | $94,718 | $22,386 |
| 2019 | 158 | 298 | 74 | 1.69 | $80,785 | $24,069 |
| 2018 | 32 | 41 | 76 | 1.88 | $5,550 | $3,300 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 43 | $7,076 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $6,089 | $107 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $4,521 | $156 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 15 | $4,239 | $283 |
| Short return visit (20+ min) | 47 | $3,874 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,344 | $147 |
| Long return visit (40+ min) | 11 | $1,942 | $129 |
| New patient visit (45+ min) | 14 | $1,447 | $103 |
| Hospital discharge day management, 30 minutes or less | 16 | $1,117 | $70 |
| Influenza vaccine split virus, preservative free | 14 | $1,007 | $72 |
| Administration of pneumococcal vaccine | 16 | $591 | $37 |
| Administration of influenza virus vaccine | 14 | $517 | $37 |
2022: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $6,804 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,625 | $179 |
| Return visit (30+ min) | 25 | $3,510 | $97 |
| Long return visit (40+ min) | 15 | $3,505 | $146 |
| Short return visit (20+ min) | 31 | $2,926 | $77 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,694 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,474 | $69 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,586 | $66 |
| Administration of influenza virus vaccine | 13 | $439 | $34 |
2021: 9 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $14,736 | $184 |
| Return visit (30+ min) | 48 | $8,449 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $6,776 | $88 |
| Long return visit (40+ min) | 20 | $5,389 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,434 | $65 |
| Short return visit (20+ min) | 25 | $2,851 | $79 |
| Hospital discharge day management, 30 minutes or less | 35 | $2,456 | $68 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,851 | $93 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,800 | $164 |
2020: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,353 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $3,528 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,994 | $65 |
| Return visit (30+ min) | 16 | $1,721 | $82 |
| Short return visit (20+ min) | 22 | $1,625 | $54 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,293 | $68 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $841 | $70 |
2019: 10 services
| Long return visit (40+ min) | 24 | $4,103 | $98 |
| Short return visit (20+ min) | 56 | $3,253 | $46 |
| Return visit (30+ min) | 29 | $2,995 | $79 |
| New patient visit (60+ min) | 14 | $2,101 | $150 |
| New patient visit (45+ min) | 14 | $1,767 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,673 | $93 |
| Hospital discharge day management, 30 minutes or less | 13 | $865 | $67 |
| Influenza vaccine split virus, preservative free | 13 | $714 | $55 |
| New patient visit (30+ min) | 11 | $576 | $52 |
| Administration of influenza virus vaccine | 13 | $267 | $21 |
2018: 1 service
| Short return visit (20+ min) | 17 | $783 | $44 |
Medicaid work
$106,656 in 2024
Medicaid paid $106,656 for 1,007 billed services this clinician did in 2024, up to 76 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 404 | $102,097 |
| Short return visit (20+ min) | 438 | $2,664 |
| 1ST HOSP IP/OBS HIGH 75 | 42 | $1,148 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 61 | $394 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 39 | $353 |
| Return visit (30+ min) | 23 | $0 |
| 2024 | 1,007 | 6 | 76 | $106,656 |
| 2023 | 1,232 | 6 | 75 | $118,034 |
| 2022 | 1,051 | 7 | 67 | $98,501 |
| 2021 | 1,955 | 8 | 93 | $182,114 |
| 2020 | 765 | 6 | 86 | $79,459 |
| 2019 | 132 | 2 | 36 | $14,053 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 477 | $114,152 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 117 | $1,443 |
| Short return visit (20+ min) | 485 | $1,307 |
| 1ST HOSP IP/OBS HIGH 75 | 19 | $555 |
| Return visit (30+ min) | 115 | $434 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 19 | $143 |
2022
| Clinic visit/encounter, all-inclusive | 401 | $93,960 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 66 | $1,482 |
| Short return visit (20+ min) | 490 | $1,479 |
| 1ST HOSP IP/OBS HIGH 75 | 34 | $1,232 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 13 | $264 |
| Short return visit | 21 | $50 |
| Return visit (30+ min) | 26 | $34 |
2021
| Clinic visit/encounter, all-inclusive | 748 | $176,034 |
| Short return visit (20+ min) | 650 | $1,678 |
| 1ST HOSP IP/OBS HIGH 75 | 52 | $1,426 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 60 | $981 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 56 | $718 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 73 | $655 |
| Short return visit | 294 | $613 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 22 | $8 |
2020
| Clinic visit/encounter, all-inclusive | 344 | $77,404 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 31 | $737 |
| Short return visit (20+ min) | 324 | $676 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $457 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 14 | $185 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 37 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 62 | $13,988 |
| Short return visit (20+ min) | 70 | $65 |
Drugs they prescribed that Part D paid
$80,925
Pharmacies billed $80,925 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (27 of 957) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
839 generic and fewer than 11 brand-name prescriptions · $80,925 in drug cost · 20 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 94 | $727 | $8 |
| Levothyroxine | 47 | $540 | $11 |
| Allopurinol | 27 | $339 | $13 |
| Duloxetine | 15 | $285 | $19 |
| Ramipril | 13 | $269 | $21 |
See all 20 drugs
| Atorvastatin | 94 | $727 | $8 |
| Levothyroxine | 47 | $540 | $11 |
| Allopurinol | 27 | $339 | $13 |
| Duloxetine | 15 | $285 | $19 |
| Ramipril | 13 | $269 | $21 |
| Lisinopril | 29 | $262 | $9 |
| Chlorthalidone | 13 | $212 | $16 |
| Trazodone | 29 | $208 | $7 |
| Metformin | 23 | $191 | $8 |
| Amlodipine Besylate | 35 | $177 | $5 |
| Gabapentin | 17 | $175 | $10 |
| Metoprolol | 20 | $153 | $8 |
| Sertraline | 17 | $147 | $9 |
| Simvastatin | 27 | $138 | $5 |
| Omeprazole | 17 | $130 | $8 |
| Losartan | 33 | $101 | $3 |
| Rosuvastatin | 17 | $92 | $5 |
| Meloxicam | 11 | $73 | $7 |
| Furosemide | 11 | $69 | $6 |
| Hydrochlorothiazide | 18 | $30 | $2 |
Year by year
| 2024 | 957 | 138 | 3% (27) | None | $80,925 |
| 2023 | 802 | 114 | 5% (40) | None | $64,137 |
| 2022 | 694 | 107 | 4% (25) | None | $79,013 |
| 2021 | 836 | 141 | 5% (45) | None | $58,228 |
| 2020 | 581 | 133 | 3% (19) | None | $35,941 |
| 2019 | 595 | 157 | 22% (129) | None | $33,058 |
| 2018 | 46 | 24 | 26% (12) | None | $1,863 |
| 2017 | 246 | 44 | 5% (11) | None | $15,274 |
| 2016 | 281 | 59 | 6% (16) | None | $14,413 |
| 2015 | 20 | None | 0% (0) | None | $2,964 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Trulicity | 11 | $14,916 | $1,356 |
| Belsomra | 12 | $4,858 | $405 |
| Atorvastatin | 80 | $842 | $11 |
| Levothyroxine | 39 | $674 | $17 |
| Pregabalin | 12 | $563 | $47 |
| Losartan | 38 | $507 | $13 |
| Valsartan | 15 | $334 | $22 |
| Tamsulosin | 11 | $324 | $29 |
| Quetiapine | 14 | $307 | $22 |
| Allopurinol | 27 | $304 | $11 |
| Trazodone | 36 | $243 | $7 |
| Lisinopril | 32 | $232 | $7 |
| Sertraline | 14 | $212 | $15 |
| Omeprazole | 20 | $187 | $9 |
| Amlodipine Besylate | 21 | $169 | $8 |
| Simvastatin | 19 | $158 | $8 |
| Furosemide | 29 | $147 | $5 |
| Oxycodone-Acetaminophen | 13 | $146 | $11 |
| Acetaminophen-Codeine | 14 | $113 | $8 |
| Metformin | 11 | $79 | $7 |
2022: 18 drugs
| Trulicity | 14 | $16,149 | $1,153 |
| Eliquis | 11 | $14,413 | $1,310 |
| Pantoprazole | 24 | $774 | $32 |
| Atorvastatin | 54 | $682 | $13 |
| Levothyroxine | 36 | $614 | $17 |
| Gabapentin | 27 | $578 | $21 |
| Valsartan | 11 | $295 | $27 |
| Losartan | 31 | $235 | $8 |
| Trazodone | 28 | $230 | $8 |
| Carvedilol | 14 | $220 | $16 |
| Amlodipine Besylate | 21 | $146 | $7 |
| Allopurinol | 17 | $145 | $9 |
| Tamsulosin | 11 | $136 | $12 |
| Omeprazole | 16 | $123 | $8 |
| Zolpidem | 13 | $106 | $8 |
| Furosemide | 13 | $80 | $6 |
| Simvastatin | 13 | $72 | $6 |
| Lisinopril | 19 | $59 | $3 |
2021: 18 drugs
| Eliquis | 24 | $18,484 | $770 |
| Buprenorphine-Naloxone | 12 | $1,150 | $96 |
| Atorvastatin | 54 | $1,145 | $21 |
| Gabapentin | 42 | $948 | $23 |
| Levothyroxine | 49 | $929 | $19 |
| Quetiapine | 11 | $654 | $59 |
| Pantoprazole | 19 | $520 | $27 |
| Losartan | 22 | $382 | $17 |
| Amlodipine Besylate | 42 | $311 | $7 |
| Hydrocodone-Acetaminophen | 19 | $305 | $16 |
| Furosemide | 23 | $197 | $9 |
| Alendronate | 14 | $178 | $13 |
| Valacyclovir | 12 | $143 | $12 |
| Trazodone | 18 | $124 | $7 |
| Allopurinol | 11 | $96 | $9 |
| Simvastatin | 20 | $82 | $4 |
| Lisinopril | 16 | $74 | $5 |
| Metformin | 14 | $42 | $3 |
2020: 14 drugs
| Eliquis | 13 | $8,974 | $690 |
| Gabapentin | 40 | $1,093 | $27 |
| Levothyroxine | 32 | $791 | $25 |
| Atorvastatin | 28 | $479 | $17 |
| Quetiapine | 11 | $418 | $38 |
| Amlodipine Besylate | 34 | $392 | $12 |
| Losartan | 19 | $234 | $12 |
| Hydrocodone-Acetaminophen | 17 | $220 | $13 |
| Clopidogrel | 13 | $183 | $14 |
| Nitrofurantoin Mono-Macro | 11 | $156 | $14 |
| Lisinopril | 14 | $107 | $8 |
| Trazodone | 17 | $93 | $5 |
| Furosemide | 13 | $78 | $6 |
| Omeprazole | 12 | $44 | $4 |
2019: 12 drugs
| Fentanyl | 31 | $1,695 | $55 |
| Gabapentin | 32 | $895 | $28 |
| Hydrocodone-Acetaminophen | 27 | $735 | $27 |
| Morphine Sulfate Er | 17 | $666 | $39 |
| Oxycodone | 25 | $623 | $25 |
| Ondansetron Odt | 13 | $413 | $32 |
| Levothyroxine | 20 | $401 | $20 |
| Atorvastatin | 17 | $335 | $20 |
| Methylphenidate | 16 | $255 | $16 |
| Amlodipine Besylate | 14 | $219 | $16 |
| Hydromorphone | 11 | $179 | $16 |
| Furosemide | 14 | $57 | $4 |
2017: 4 drugs
| Lantus | 23 | $7,125 | $310 |
| Levothyroxine | 21 | $333 | $16 |
| Simvastatin | 19 | $142 | $7 |
| Gabapentin | 12 | $127 | $11 |
2016: 6 drugs
| Lantus | 22 | $5,631 | $256 |
| Levothyroxine | 38 | $489 | $13 |
| Gabapentin | 17 | $213 | $13 |
| Simvastatin | 25 | $104 | $4 |
| Sertraline | 15 | $96 | $6 |
| Hydrochlorothiazide | 13 | $53 | $4 |
Money from drug and device companies
$62 in 2025
A payment is not proof that care is biased.
| Pfizer | Prevnar 20 | $36 | 1 payment
|
| GlaxoSmithKline | Bexsero | $26 | 1 payment
|
See all 2 published payments
| Pfizer | Meals · 2025-12-04 | Prevnar 20 | $36 |
| GlaxoSmithKline | Meals · 2025-08-02 | Bexsero | $26 |
Professional record
- NPI
- 1619381779
- Licence
- CA A139134California A139134: Current · expires 2027-11-30
- Trained
- University of California, Geffen School of Medicine, 2014
- Group
- Indian Health Center of Santa Clara Valley · University Healthcare Alliance
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Federal specialty code 207QH0002X (207QH0002X)
- Mailing address
- 960 N San Antonio Rd Ste 101, Los Altos, CA, 94022
- NPI first listed
- 2014-06-17
- NPI last updated
- 2018-10-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4150 V St Ste 3400, Sacramento, CA, 95817